FUND+ PEOPLE INVESTMENT STRATEGY PORTFOLIO YOUR PROJECT NEWS CONTACT US INVESTMENT STRATEGY What services do we provide? LONG TERM PARTNER Fund+ invests in and supports innovative companies Our mission Fund+ aims to become a significant minority shareholder (more than 10%) and offers access to a wide international network within the scientific, academic and financial community. The intended investment size per project will be between EUR 5 million and EUR 15 million. Fund+ plays a constructive role as board member in our portfolio companies. Fund+ wants to become a long term partner of companies, create value for its shareholders and generate and formally evaluate a tangible beneficial societal impact. The societal impact will be evaluated by using a proprietary SRI scorecard that is based on the SRI policy that you can find here. What we stand for? active in life sciences (primary focus on therapeutics, not excluding diagnostics and medical devices), with a strong patient-centric approach addressing unmet medical needs in an advanced development stage (first round and subsequent financing) with an experienced management team respecting highest ethical values presenting a solid business plan invest in Europe, with a focus on Belgium PORTFOLIO Everything You Need to Know Contact us Address: Groot Begijnhof 60 3000 Leuven Belgium Phone: +32 (0)16 90 50 00 Email: info@fundplus.be Recent Articles ONA Therapeutics Appoints Dr Michel Detheux as Independent Chair to Board of Directors Confo Therapeutics Enters Collaborative Agreement with Regeneron Immunic, Inc. Announces Enrollment of First Patient in its Phase 3 ENSURE Program of vidofludimus calcium (IMU-838) in Relapsing Multiple Sclerosis © 2019 FUND+- ALL RIGHTS RESERVED. | We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPTRead More